Today's New Buy Pick - Xenon Pharmaceuticals Inc. (XENE)

[Tesla]( said it plans to offer $2 billion in common stock, taking advantage of its recent surging shares,  with analysts and investors cheering the move as a way to shore up its  balance sheet and potentially further expansion plans. “It’s a smart,  strategic move,” said Wedbush analyst Dan Ives. “It takes any doomsday  scenario around cash crunch… off the table.” CEO Elon Musk said he will  buy as much as $10 million ... Datasea Inc (NASDAQ: [DTSS](  Datasea shares jumped as much as 50% yesterday after the company  announced that has six agreements to provide services to K-12 schools  and public communities in the Chinese cities of Nanjing and Taiyuan with  infrared thermometers and related hardware and software solutions in an  effort to detect and control the COVID-19 outbreak. “We believe that  our surveillance systems ... [Read More]( [Top 5 Midcap Stocks set to Double in 2020]( While 2020 could be rocky with the U.S. elections nearing, we've spotted some of the strongest stocks to own now that could double, if not triple your investment. In our latest special report, we detail five of the hottest mid-cap stocks that should be part of your portfolio right now. (ad) [Click Here to Download the FREE Report](  [Trump Says He Wants 5G...Does That Mean You Should Invest?]( Could 5G be the greatest investment opportunity of 2020? Our President, Donald J. Trump has said...Click here to receive your free report "The Top 3 5G Stocks Anyone Could Invest In... Even Trump"... (ad) [Inside you'll find out the names of the three companies that could dominate plus you'll receive daily commentary from Axe Daily.](  [CUK is a stock that could be facing a big hit from the coronavirus in 2020]( While investors have been anxious to find reasons to shrug off fears  about the economic impact of coronavirus, there are certainly some  individual cases where those risks can’t really be ignored. One in the  Leisure & Recreation Services industry, which includes cruise line  companies. [Read More](  [An Urgent Warning For All Americans]( - Please pay close attention. America is at risk of what's been called an inevitable "Cyber 9/11." This is a terrorist attack - or act of war - conducted through computers, via cyberspace. But all hope is not lost. We've released our research on this threat free and to the public. Is a "Cyber 9/11" attack imminent? (ad)  [Read more here...]( Featured Stock [Xenon Pharmaceuticals Inc. (XENE) – Buy Target – $17.50 or better]( Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company,   engages in developing therapeutics to treat patients with neurological   disorders in Canada. Its clinical development pipeline include XEN496, A   Kv7 potassium channel modulator that is Phase II clinical trials for   the treatment of KCNQ2 epilepsy; XEN1101, A Kv7 potassium channel   modulator, which is in Phase II clinical trial for the treatment of   epilepsy. Other Top Stories [Stocks open lower on Wall Street as virus cases spike]( [Free tax filing has confused many Americans. Here's help.]( [US mortgages flat to slightly higher; 30-year loan at 3.47%]( [New Mexico bid for recreational marijuana all but doomed](  Sponsor [FREE REPORT: Discover Manhattan's Secret 10.6% Bank]( One undiscovered bank expects to pay out $332 million in 2019! And now's your chance to claim a 10.6% dividend - with MONTHLY PAYMENTS. This FREE special report reveals important details - including NAME, TICKER SYMBOL, and urgent payment information. [Click here to download your report ASAP.](  Trend Following Picks [(GNPX) – Buy Target – $1.85 or better]( [(GNRC) – Buy Target – $112.30 or better]( [(MRNA) – Buy Target – $24.00 or better]( [(KMDA) – Buy Target – $7.25 or better]( [(NVMI) – Buy Target – $41.00 or better]( [All Picks]( Reversal Picks [(CRSP) Buy Target $59.48  Sell Target $65.02]( [(DRRX) Buy Target $2.48  Sell Target $3.04]( [(CMPR) Buy Target $119.01 Sell Target $128.97]( [(NEW) Buy Target $9.12  Sell Target $10.06]( [(EMMS) Buy Target $4.08  Sell Target $4.43]( [All Picks](  Already subscribed to our premium service? [Click here to Login]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here -  Learn The # 1 Key To Successful Stock Investing Profits](                                --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019